1. Academic Validation
  2. Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity

Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity

  • J Med Chem. 2015 Oct 22;58(20):7938-48. doi: 10.1021/acs.jmedchem.5b00687.
Thomas C Eadsforth 1 Andrea Pinto 2 Rosaria Luciani 3 Lucia Tamborini 2 Gregorio Cullia 2 Carlo De Micheli 2 Luciana Marinelli 4 Sandro Cosconati 5 Ettore Novellino 4 Leonardo Lo Presti 6 Anabela Cordeiro da Silva 7 Paola Conti 2 William N Hunter 1 Maria P Costi 3
Affiliations

Affiliations

  • 1 Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee , Dow Street, Dundee DD1 5EH, U.K.
  • 2 Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano , Via Mangiagalli 25, 20133 Milano, Italy.
  • 3 Department of Life Science, University of Modena and Reggio Emilia , Via Campi 103, 41125, Modena, Italy.
  • 4 Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II" , Via Montesano 49, 80131 Napoli, Italy.
  • 5 DiSTABiF, Seconda Università di Napoli , Via Vivaldi 43, 81100 Caserta, Italy.
  • 6 Dipartimento di Chimica, Università degli Studi di Milano , Via Golgi 19, 20133 Milano, Italy.
  • 7 Instituto de Investigação e Inovação em Saúde, Instituto de Biologia Molecular e Cellular da Universidade do Porto, Departamento de Ciências Biológicas, Universidade do Porto , Porto, Portugal.
Abstract

The bifunctional Enzyme N(5),N(10)-methylenetetrahydrofolate dehydrogenase/cyclo hydrolase (FolD) is essential for growth in Trypanosomatidae. We sought to develop inhibitors of Trypanosoma brucei FolD (TbFolD) as potential antiparasitic agents. Compound 2 was synthesized, and the molecular structure was unequivocally assigned through X-ray crystallography of the intermediate compound 3. Compound 2 showed an IC50 of 2.2 μM, against TbFolD and displayed antiparasitic activity against T. brucei (IC50 49 μM). Using compound 2, we were able to obtain the first X-ray structure of TbFolD in the presence of NADP(+) and the inhibitor, which then guided the rational design of a new series of potent TbFolD inhibitors.

Figures